MIRM Q3'26 Earnings Preview: EPS Estimate at (0.49) USD
Mirum Pharmaceuticals is scheduled to report Q3'26 results on November 03 after the market closes. Revenue is estimated at 178.08 million USD and EPS at (0.49) USD.
Related stories
Oracle Announces $10 Million Stock and $10 Billion Bond Deals
Oracle shares fell after the company announced stock and bond deals.
M impact | EQUITY | Nov 02, 2026, 01:47 PM UTC
Oracle-Aktien geben nach Ankündigung von Aktien- und Anleihegeschäften nach
Oracle-Aktien fallen nach Bekanntgabe von Aktiengeschäften im Wert von 10 Milliarden US-Dollar und Anleihegeschäften im Wert von 10 Milliarden US-Dollar.
L impact | EQUITY | Nov 02, 2026, 01:44 PM UTC
Navios Maritime Holdings Raises Tender Offer Price to $16, Extends Deadline
Navios Maritime Holdings increased the tender offer price and extended the expiration date for its cash offer to purchase Series G and Series H American Depositary Shares.
M impact | EQUITY | Nov 02, 2026, 01:44 PM UTC
Krystal Biotech Q3 Net Income Falls, Revenue Rises
M impact | EQUITY | Nov 02, 2026, 01:44 PM UTC
Infineon shares rise 3.6%
M impact | EQUITY | Nov 02, 2026, 01:43 PM UTC
Out West Restaurant Group Files for Chapter 11 Bankruptcy
The filing covers 61 Outback Steakhouse locations.
M impact | EQUITY | Nov 02, 2026, 01:42 PM UTC